Revolutionizing Gene Therapy Trials with Decentralized Manufacturing and Patient-Centric Approaches

Time: 2:45 pm
day: Day 2


  • Exploring the challenges and opportunities associated with decentralizing gene therapy trials
  • Addressing the attachment of physicians from a sponsor’s perspective and the complexities in oversight when patients are assessed at multiple sites
  • Assessing the challenges of implementing home healthcare in gene therapy trials
  • Investigating innovative approaches, such hybrid models, to enhance the patient experience in gene therapy trials